002603 Shijiazhuang Yiling Pharmaceutical

Watchlist

16.31
+0.14+0.87%

Market Closed Dec 27 15:00 CST

27.25BMarket Cap183.26P/E (TTM)

About Shijiazhuang Yiling Pharmaceutical Company

The company was founded on June 16, 1992. The company took “inheriting innovation and benefiting humanity” as the corporate purpose, “science and technology for a healthy tomorrow”, “seeking development for employees, contributing to society, and creating value for shareholders” as the business philosophy, always adhering to the innovative development strategy of leading technology and market leaders. For the first time, the company systematically constructed a complex disease theory system, and founded a five-in-one “theory - clinical research - industry - teaching” industrial development cluster “from medicine to medicine to health”. “Traditional Chinese medicine complex disease diagnosis and treatment methods” are included in the national intangible cultural Heritage, Complexology 》It became a university textbook, and courses have been launched at more than 40 colleges and universities across the country. The company's main business is R&D, production and sales of patented innovative traditional Chinese medicines. The company's main products include Tongxinluo capsules, Shensong Yangxin capsules, Qiangxin capsules, Lianhua Qingfeng capsules, Lianhua Qingfeng capsules, Lianhua Cough tablets, Jinlida granules, Tongluo Mingmu capsules, Kidney Health Relief Tablets, Antidepressant capsules, Zizheng Anshen Oral Liquid OTC products, Yangzheng Anshen capsules, Shenling Blue capsules, Bazi Kidney Supplements capsules, Xia Li Qi capsules, etc. Corporate honors: Ranked first in the “2023 Chinese Medicine Innovative Brand Enterprise” list, won the “Top 100 Most Valuable Companies on the Main Board”, was selected for the “Top 100 Companies in China Pharmaceutical Industry Quality Award”, selected as “2023 Top 30 Pharmaceutical Industry Competitiveness”, ranked 5th in the 2022 Chinese Traditional Chinese Medicine Enterprise TOP100 list, selected for the CCTV “China ESG Listed Companies Pioneer 100” list, and was selected for the China Top 100 Innovative Brands, selected for the Xinhua News Agency Brand Project, Hebei Enterprise Technology Innovation Award, National Advanced Private Enterprise for Employment and Social Security, 2020 In July, Eling Pharmaceutical ranked 10th in the “2019 Top 100 Chinese Medicine Companies List” (China Pharmaceutical Industry Top 100 Series List) and won the honorary title of “High-Level Innovation Team”.

Company Profile

Short Name-A以岭药业

Symbol-A002603

Company NameShiJiaZhuang YiLing Pharmaceutical Co., Ltd

Listing DateJul 28, 2011

Issue Price34.56

Shares Offered65.00M share(s)

FoundedAug 28, 2001

Listed ExchangeSZ Stock Exchange

Legal Representativexiangjun wu

General Managerxiangjun wu

Secretaryrui wu

Accounting FirmZhongqin Wanxin Certified Public Accountants Co., Ltd. (Special General Partnership)

Securities Representativehua wang

Legal CounselBeijing Guofeng Law Firm

Employees10809

Phone0311-85901311

Office AddressNo. 238 Tianshan Street, High-tech Industrial Development Zone, Shijiazhuang City, Hebei Province

Zip Code050035

Registered AddressNo. 238 Tianshan Street, High-tech Industrial Development Zone, Shijiazhuang City, Hebei Province

Fax0311-85901311

Email002603@yiling.cn

Websitehttp://www.yiling.cn

Business License130000000018406

BusinessProduction and sale of hard capsules, tablets, granules, compounds, small-volume injections, traditional Chinese medicine formula granules, and plastic packaging containers for food; production and sale of health food products (subject to approval in the Food Production License List); Production and sale of beverages (solid beverages, other beverages) (food types permitted to be produced are subject to approval on the food production license subpage); production and sale of convenience foods (the types of food products licensed for production are subject to approval on the food production license subpage); production of traditional Chinese medicine extracts; production and technical consultation on Chinese herbal medicine extracts, services, transfers ; Manufacture and sale of Chinese herbal medicine tablets (purified, cut, steamed, boiled, stir-fried, charcoal, simmered, moxibustion, stewed, forged, steamed, and dried). We are self-employed and agents in the import and export of various commodities and technologies, with the exception of goods and technology operated by state-restricted companies; leasing of own houses; leasing of machinery and equipment; leasing of furniture and household appliances; acquisition of agricultural products (excluding food); wholesale and retail of primary agricultural products; production and sale of confectionery products (subject to approval on the subpage of the food production license); business management consulting services; general freight, special transportation of goods (refrigeration and preservation); health management consulting services (excluding diagnosis, medical treatment, and psychological counseling). (Limited to branch operations); Research and development of proprietary Chinese medicines, pharmaceuticals and health products, traditional medical devices, Western medicines, biological products, and hygiene accessories; technical consultation, service, and transfer; (For projects subject to approval according to law, business activities can only be carried out after approval by relevant departments).

Company Executives

Name
Position
Salary

xiangjun wu
Chairman, directors, general manager, Strategy and Planning Committee (convener), Nomination Committee Members
3.15M

rui wu
Directors, Board Secretary, Member of the Strategy and Planning Committee
1.83M

qiulian zhang
Directors, Deputy General Manager
2.16M

weidong xu
Directors, Member of the Remuneration and Assessment Committee
939.10K

chenguang li
Directors, Head of Finance, Member of the Strategy and Planning Committee
1.83M

shaohua zhao
Directors
971.80K

xiaohan liu
Independent directors, Member of the Strategy and Planning Committee, Member of the Remuneration and Assessment Committee, Nomination Committee (Convener), Audit Committee Member
116.60K

zhenguo chai
Independent directors, Audit Committee Member, Member of the Remuneration and Assessment Committee (Convener), Nomination Committee Members
--